what exactly does semaglutide do to your body Should I Expect During the First Week of GLP-1 Semaglutide has become one of

Importantly, GLP-1 receptor agonists should not be combined with DPP-4 inhibitors, as this provides minimal additional benefit

Drugs like semaglutide (Wegovy) and tirzepatide (Zepbound) have shown to improve efficacy compared to older weight-loss medications, with patients losing up to 20% of their body weight

Kobroob et al., 2012

MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Inherits side-effect profiles of all three components Known interactions Per-component interactions apply Contraindications Active malignancy (theoretical all three components are pro-angiogenic) Pregnancy/lactation (unstudied) REGULATORY STATUS FDA Not FDA-approved as a combined product